Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AC Selective beta-2-adrenoreceptor agonists
R03AC13 Formoterol
D01373 Formoterol fumarate (USP) <US>
R03C ADRENERGICS FOR SYSTEMIC USE
R03CC Selective beta-2-adrenoreceptor agonists
R03CC15 Formoterol
D01373 Formoterol fumarate (USP) <US>
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01052 Formoterol
D01373 Formoterol fumarate
Metabolizing enzyme substrate
DG02924 UGT substrate
DG01052 Formoterol
D01373 Formoterol fumarate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D01373 Formoterol fumarate (USP) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01373
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01373
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01373
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01052 Formoterol
Metabolizing enzyme substrate
DG02924 UGT substrate
DG01052 Formoterol